Found: 19
Select item for more details and to access through your institution.
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 3, p. N.PAG, doi. 10.1093/ofid/ofy031
- By:
- Publication type:
- Article
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants.
- Published in:
- Infectious Diseases & Therapy, 2018, v. 7, n. 1, p. 121, doi. 10.1007/s40121-017-0178-6
- By:
- Publication type:
- Article
Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States.
- Published in:
- Infectious Diseases & Therapy, 2017, v. 6, n. 4, p. 477, doi. 10.1007/s40121-017-0167-9
- By:
- Publication type:
- Article
Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes.
- Published in:
- Infectious Diseases & Therapy, 2015, v. 4, n. 4, p. 503, doi. 10.1007/s40121-015-0097-3
- By:
- Publication type:
- Article
The Medicaid Cost of Palivizumab.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Healthcare costs within a year of respiratory syncytial virus among medicaid infants.
- Published in:
- Pediatric Pulmonology, 2010, v. 45, n. 8, p. 772, doi. 10.1002/ppul.21244
- By:
- Publication type:
- Article
BRCA screening, treatment patterns and response among patients with ovarian cancer in the second line treatment setting: results from a real world survey.
- Published in:
- European Journal of Gynaecological Oncology, 2022, v. 43, n. 2, p. 202, doi. 10.31083/j.ejgo4302026
- By:
- Publication type:
- Article
Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm Infants.
- Published in:
- Clinical Pediatrics, 2019, v. 58, n. 8, p. 837, doi. 10.1177/0009922819843639
- By:
- Publication type:
- Article
The Logistics and Coordination of Respiratory Syncytial Virus Immunoprophylaxis Use Among US Pediatric Specialists.
- Published in:
- Clinical Pediatrics, 2016, v. 55, n. 13, p. 1230, doi. 10.1177/0009922815621343
- By:
- Publication type:
- Article
Perceived Risk of Severe Respiratory Syncytial Virus Disease and Immunoprophylaxis Use Among US Pediatric Specialists.
- Published in:
- Clinical Pediatrics, 2016, v. 55, n. 8, p. 724, doi. 10.1177/0009922815604598
- By:
- Publication type:
- Article
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma.
- Published in:
- Respiratory Research, 2013, v. 14, n. 9, p. 1, doi. 10.1186/1465-9921-14-93
- By:
- Publication type:
- Article
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US.
- Published in:
- Pediatric Health, Medicine & Therapeutics, 2019, v. 10, p. 21, doi. 10.2147/PHMT.S182296
- By:
- Publication type:
- Article
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.
- Published in:
- PharmacoEconomics, 2020, v. 38, n. 11, p. 1201, doi. 10.1007/s40273-020-00949-9
- By:
- Publication type:
- Article
Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152208
- By:
- Publication type:
- Article
Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0205399
- By:
- Publication type:
- Article
Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2544, doi. 10.1007/s12325-022-02086-5
- By:
- Publication type:
- Article
Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 328, doi. 10.1007/s12325-021-01959-5
- By:
- Publication type:
- Article
A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 575, doi. 10.1007/s40487-021-00162-4
- By:
- Publication type:
- Article